rasagiline

The drug is used for the treatment of idiopathic Parkinsonism as monotherapy, as well as an adjunct therapy when used with dopamine agonists or levodopa (particularly when end-of-dose levodopa fluctuations are observed).

Form: tablets

ATC: N04BD02

Manufacturer: Dzhenefarm SA (manufacturing, primary and secondary packaging, quality control and batch release)

The drug is used for the treatment of idiopathic Parkinsonism. It may be prescribed as monotherapy or as an adjunct to the use of dopamine agonists or levodopa.

Form: tablets

ATC: N04BD02

Manufacturer: Teva Pharmaceutical Industries Ltd. (Manufacturers responsible for manufacturing unpackaged product, primary packaging, secondary packaging, batch control, batch release)

The drug is used for the treatment of idiopathic Parkinsonism as a monotherapy, as well as an adjunct treatment when used with dopamine agonists or levodopa (particularly when end-of-dose fluctuations are observed).

Form: tablets

ATC: N04BD02

Manufacturer: Macleods Pharmaceuticals Limited

The drug is used for the treatment of idiopathic Parkinsonism. It may be prescribed as monotherapy or as adjunctive therapy in combination with dopamine agonists or levodopa.

Form: tablets

ATC: N04BD02

Manufacturer: NOBEL ILAC SANAYI VE TICARET A.S.

The drug is used for the treatment of idiopathic Parkinsonism. It can be used either as monotherapy or in combination with levodopa (adjuvant therapy).

Form: tablets

ATC: N04BD02

Manufacturer: KRKA, d.d., Novo Mesto (manufacturing 'in bulk', primary and secondary packaging, batch control and batch release) / KRKA, d.d., Novo Mesto (batch control) / KRKA, d.d., Novo Mesto (batch control)

The drug is used for the treatment of idiopathic Parkinsonism. It can be used as monotherapy or as an add-on treatment to levodopa in the presence of end-of-dose fluctuations.

Form: tablets

ATC: N04BD02

Manufacturer: Medocemi Limited (manufacturing of finished medicinal product, primary and secondary packaging, quality control, batch release)